- Home
- STK vs BVS Comparison
STK vs BVS Comparison
Compare STK & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STK | BVS |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.8M | 716.8M |
| IPO Year | 2009 | 2016 |
Fundamental Metrics
Financial Performance| Metric | STK | BVS |
|---|---|---|
| Price | $50.79 | $8.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 76.2K | ★ 660.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ N/A | $226.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.91 | $5.81 |
| 52 Week High | $58.46 | $11.25 |
Technical Indicators
Market Signals| Indicator | STK | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 47.99 | 42.14 |
| Support Level | $34.67 | $8.55 |
| Resistance Level | $52.04 | $9.24 |
| Average True Range (ATR) | 2.10 | 0.48 |
| MACD | -0.97 | 0.00 |
| Stochastic Oscillator | 31.03 | 48.46 |
Price Performance
Historical ComparisonAbout STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.